Panagora Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Panagora Asset Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	227,579 +122,835	+117%	+$784K	0.01%	657
2026 Q1	$608K	Buy	+104,744	New	+$695K	﹤0.01%	810
2025 Q2	–	Sell	-145,526	Closed	-$799K	–	1226
2025 Q1	$799K	Buy	+145,526	New	+$587K	﹤0.01%	705
2024 Q1	–	Sell	-140,318	Closed	-$330K	–	1269
2023 Q4	$330K	Sell	140,318 -109,882	-44%	-$203K	﹤0.01%	1076
2023 Q3	$465K	Sell	250,200 -37,400	-13%	-$85.7K	﹤0.01%	990
2023 Q2	$754K	Buy	+287,600	New	+$732K	﹤0.01%	874
2021 Q2	–	Sell	-2,576	Closed	-$12K	–	2974
2021 Q1	$12K	Hold	2,576	–	–	﹤0.01%	2369
2020 Q4	$13K	Sell	2,576 -5,829	-69%	-$29.2K	﹤0.01%	2256
2020 Q3	$50K	Hold	8,405	–	–	﹤0.01%	2017
2020 Q2	$22K	Hold	8,405	–	–	﹤0.01%	2128
2020 Q1	$16K	Buy	+8,405	New	+$36.1K	﹤0.01%	2082

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Panagora Asset Management's XERS Position: Q2 2026 in Review

Panagora Asset Management increased its Xeris Biopharma Holdings (XERS) stake by 117% in Q2 2026, buying an estimated $784K and bringing the position to 227,579 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #657.

Panagora Asset Management first reported a position in XERS in Q1 2020 and has held it in 11 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Panagora Asset Management held 227,579 shares of Xeris Biopharma Holdings worth $1.8M as of Q2 2026.
Panagora Asset Management bought 122,835 Xeris Biopharma Holdings shares in Q2 2026, an estimated $784K.
Xeris Biopharma Holdings made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #657 holding.
Panagora Asset Management first reported a position in Xeris Biopharma Holdings in Q1 2020 and has held it in 11 quarters since.
240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.